<![CDATA[Sanofi ]]>enghttp://www.nasdaqomx.comCopyright (c)2014 NASDAQ OMXhttp://blogs.law.harvard.edu/tech/rssNASDAQ OMX - http://www.nasdaqomx.com/onlineservices@nasdaqomx.com (NASDAQ OMX)onlineservices@nasdaqomx.com (NASDAQ OMX)10<![CDATA[Sanofi ]]>http://www.huginonline.com/France/SANOFI/logo.jpghttp://www.huginonline.com450160<![CDATA[Sanofi Appoints Robert Castaigne as Audit Committee Chairman]]>Fri, 6 Mar 2015 16:00:00 +0100http://cws.huginonline.com/S/152918/PR/201503/1900166_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201503/1900166_5.htmlhttp://hugin.info/152918/R/1900166/675290.pdf<![CDATA[Toujeo® Receives Positive Opinion from the European Regulatory Authorities]]>Fri, 27 Feb 2015 13:15:43 +0100http://cws.huginonline.com/S/152918/PR/201502/1897975_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201502/1897975_5.htmlhttp://hugin.info/152918/R/1897975/673928.pdf<![CDATA[Sanofi Receives FDA Approval of Once-Daily Basal Insulin Toujeo®]]>Thu, 26 Feb 2015 02:00:58 +0100http://cws.huginonline.com/S/152918/PR/201502/1897483_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201502/1897483_5.htmlhttp://hugin.info/152918/R/1897483/673570.pdf<![CDATA[Sanofi : Sanofi Appoints Olivier Brandicourt as Chief Executive Officer ]]>Thu, 19 Feb 2015 22:45:00 +0100http://cws.huginonline.com/S/152918/PR/201502/1896027_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201502/1896027_5.htmlhttp://hugin.info/152918/R/1896027/672616.pdf<![CDATA[Sanofi: Sanofi and Lead Pharma to Develop Treatments for Autoimmune Diseases ]]>Wed, 18 Feb 2015 07:00:00 +0100http://cws.huginonline.com/S/152918/PR/201502/1895071_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201502/1895071_5.htmlhttp://hugin.info/152918/R/1895071/675301.pdf<![CDATA[Sanofi : ENGAGE Randomized Clinical Trial Evaluating Cerdelga® (eliglustat) for Treatment-Naïve Patients with Gaucher Disease Type 1 Published in The Journal of the American Medical Association]]>Tue, 17 Feb 2015 17:31:17 +0100http://cws.huginonline.com/S/152918/PR/201502/1895162_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201502/1895162_5.htmlhttp://hugin.info/152918/R/1895162/672031.pdf<![CDATA[Sanofi: Sanofi delivers Business EPS(1) growth of 7.3% at CER in 2014]]>Thu, 5 Feb 2015 07:30:00 +0100http://cws.huginonline.com/S/152918/PR/201502/1891752_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201502/1891752_5.htmlhttp://hugin.info/152918/R/1891752/670785.pdf<![CDATA[Sanofi : Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now Available in the U.S. ]]>Tue, 3 Feb 2015 07:00:00 +0100http://cws.huginonline.com/S/152918/PR/201502/1892844_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201502/1892844_5.htmlhttp://hugin.info/152918/R/1892844/670774.pdf<![CDATA[Sanofi : Sanofi and Regeneron Announce Praluent(TM) (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA]]>Mon, 26 Jan 2015 07:00:00 +0100http://cws.huginonline.com/S/152918/PR/201501/1889253_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201501/1889253_5.htmlhttp://hugin.info/152918/R/1889253/668680.pdf<![CDATA[Sanofi : European Commission Grants Marketing Authorization for Cerdelga® (eliglustat), Genzyme's Oral Therapy for Gaucher Disease Type 1]]>Thu, 22 Jan 2015 07:00:00 +0100http://cws.huginonline.com/S/152918/PR/201501/1888437_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201501/1888437_5.htmlhttp://hugin.info/152918/R/1888437/668415.pdf